S&P 500, Nasdaq steady after record high closes amid hopes for renewed Iran truce

🚚 Why J B Hunt Transport shares are trading higher

Shares of J B Hunt Transport Services Inc rose in pre-market trading, after the company reported upbeat earnings for the first quarter.

The company posted quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.45 per share.

The company reported quarterly sales of $3.056 billion which beat the analyst consensus estimate of $2.940 billion.

J B Hunt Transport shares gained 2% to $228.60 in pre-market trading. Benzinga reports.


⛏️ Titan Mining commences graphite shipments from New York demonstration facility

Titan Mining shares rose 4.7% in U.S. premarket trading after the company announced it sees significant potential to expand its Kilbourne project.

This increase follows positive exploration updates and project development plans for the site. Yahoo Finance reports.


💻 Microsoft’s stock has sprung back to life and is on its strongest run in 3 years, by one measure

Microsoft’s stock still has a ways to go before reclaiming its highs, but for now, it’s on a notable hot streak.

Microsoft shares rose 4.6% on Wednesday and have climbed 10.9% across a three-day span.

The daily performance was the stock’s best since a 7.6% climb seen on May 1 of last year, according to Dow Jones Market Data.

And over a three-session span, Microsoft shares delivered their best such performance since the stretch that ended April 28, 2023, when they rose 11.6%. MarketWatch reports.


🧬 Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

Hims & Hers Health’s plan to enter the business of selling peptides is looking a lot more realistic.

Health and Human Services Secretary Robert F. Kennedy Jr. announced Wednesday afternoon that the U.S. government will loosen regulations for 12 peptides, which are used like supplements for health reasons, that were put in place in 2023 for safety reasons.

The Food and Drug Administration also scheduled a meeting this summer to talk about whether seven peptides can be produced by compounding pharmacies in a move that would make them more widely MarketWatch reports.


💊 Abbott results beat on medical device boost, Exact deal hits forecast

Abbott marginally beat Wall Street estimates for quarterly profit and revenue on Thursday, partially helped by its newly acquired cancer diagnostics business.

However, its shares were down 2% before the bell, after the company said its 2026 profit forecast will see a 20 cent hit due to its recent $23 billion acquisition of cancer test maker Exact Sciences. Yahoo Finance reports.

Time (ET)/ Report/ Period

8:30 AM - Initial jobless claims - April 11
8:30 AM - Philadelphia Fed manufacturing survey - April
8:35 PM - New York Fed President John Williams speaks - N/A

“There is nothing new in Wall Street. There can’t be because speculation is as old as the hills.”

– Jesse Livermore

Sourced in: Reminiscences of a Stock Operator — GoodReads.

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference. There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses. Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.